NEUROMOD+
Representing UK research, industry, clinical and patient communities, working together to address the challenge of minimally invasive treatments for brain disorders
Funding call 2023
Deadline to apply: 21 April 2023
A total of £300,000 is available in 2023 to fund feasibility studies and other network activities.
About us
The EPSRC & MRC NEUROMOD+ Network is a new UK network aiming to build capacity and bring together multidisciplinary stakeholder groups to support the co-creation of novel neuromodulation therapies. NEUROMOD+ will promote and facilitate discussion between stakeholders, and instigate new collaborative research partnerships, through a range of activities including co-creation events, workshops and funding calls.
Neuromod+ is managed through a consortium of four UK universities: Imperial College London and the Universities of Nottingham, Oxford and Edinburgh. The network was inspired by multidisciplinary collaborations established through the Imperial College Centre of Excellence in Neurotechnology.
Our team
Simon Schultz
Network Lead
Simon is Professor of Neurotechnology in the Dept of Bioengineering and Director of the Centre of Excellence in Neurotechnology, at Imperial College London. His research interests are in developing neurotechnology for interrogating neural circuits and applying it to understanding cognitive brain function and neurodegeneneration. He leads the Network executive, as well as leading a project on the development of cerebral organoid technology for testing minimally invasive neuromodulation technologies.
Hayriye Cagnan
Network Co-I
Hayriye is an Associate Professor and MRC Career Development Fellow in the Medical Research Council Brain Network Dynamics Unit at the University of Oxford. Her research focuses on developing novel stimulation approaches to increase therapy efficacy and specificity. In recent years, she has been extending her work on implantable bioelectronics to wearable non-invasive stimulation strategies. She currently serves on the College of Experts for Parkinson’s UK.
Sarah Chan
Network Co-I
Sarah is a Reader in Bioethics at the Usher Institute, University of Edinburgh, an Associate Director of the Centre for Biomedicine, Self and Society and a Deputy Director of the Mason Institute for Medicine, Life Sciences and Law. Sarah’s research focuses on the ethics of new biomedical technologies. Her current work explores the ethics of emerging modes of biomedicine at the interface of health care research, medical treatment and consumer medicine.
Rylie Green
Network Co-I
Rylie is Professor of Polymer Bioelectronics and Head of the Dept of Bioengineering at Imperial College London. She is a global leader in the field of Polymer Bionics, where she has pioneered the concept of the living electrode. Her research is focused on the development of bioactive and novel polymer electronics, with a specific objective of delivering new high-resolution technologies to the market.
Marcus Kaiser
Network Co-I
Marcus is Professor of Neuroinformatics at University of Nottingham and leader of Neuroinformatics UK, representing 600+ researchers in the field. Research interests are understanding the origin of brain disorders through modelling brain development and using models to inform therapeutic interventions, in particular using non-invasive brain stimulation. He is currently PI for an EPSRC Transformative Healthcare Technologies grant on using focused ultrasound for non-invasive brain stimulation.
Kate Hobson
Network Manager
Kate is responsible for the day to day running of the network. She also manages the Centre for Neurotechnology and associated EPSRC Centre for Doctoral Training in Neurotechnology at Imperial College London. In a previous life, she was a volcanologist, and completed her PhD in volcanology at University of Oxford in 2001.
Upcoming events
Previous events
